Quick Answer
Jade Biosciences, Inc. reported Research And Development Expense of $93.12 million for the year ending 2025.
- Jade Biosciences, Inc. showed an increase of +75.1% in Research And Development Expense from 2024 to 2025.
- This data is from Jade Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.47 million | Q3 2020: $1.97 million | Q1 2021: $2.20 million | Q2 2021: $4.33 million | Q3 2021: $3.42 million | Q1 2022: $7.26 million | Q2 2022: $8.36 million | Q3 2022: $10.78 million | Q1 2023: $13.49 million | Q2 2023: $16.03 million | Q3 2023: $16.88 million | Q1 2024: $20.08 million | Q2 2024: $21.25 million | Q2 2024: $78.0 thousand | Q3 2024: $13.58 million | Q2 2025: $22.55 million | Q3 2025: $22.01 million.
- Over the full 6 years of available data (2020 to 2025), Jade Biosciences, Inc.'s Research And Development Expense has grown by 1,072.8%.
- Historical annual values: Fiscal year 2025: $93.12 million | Fiscal year 2024: $53.19 million | Fiscal year 2023: $64.22 million | Fiscal year 2022: $38.62 million | Fiscal year 2021: $14.99 million | Fiscal year 2020: $7.94 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: